Delivery Order SPE2DB20D3103-SPE2DB24FM0Q3
Award Date
12/26/23
Potential Completion Date
1/18/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $7,018.24 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,754.58 firm fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts to provide a wide range of prescription medications, medical supplies, and equipment to various government agencies and healthcare programs....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ZOLADEX 3.6 MG IMPLANT SYRNS pharmaceutical product. The contract has a ceiling value of $2,498.32 and a period of performance through April 10, 2024. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued at up to...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,606,804 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price ceiling value of $1,754.58 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this delivery order contract without any set-aside...
The Defense Logistics Agency (DLA) awarded a $8,772.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565703763 ZOLADEX 10.8 MG IMPLANT SYRNS. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a range of essential medical commodities from Amerisourcebergen to...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,677.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication. The award was made on December 23, 2022, with a completion date of January 18, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a ceiling value of $10,527.36 and a performance period through April 18, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a potential value of $3,509.16 and a completion date of January 31, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS. The contract, valued at $1,873.74, is a Firm Fixed Price Delivery Order with a completion date of September 16, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which does not have a set-aside designation. The contract is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,735.50, is a Firm Fixed Price Delivery Order to provide ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...